ArticlePloS one2015

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.

Sara Charmsaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.